The role of complement in arterial hypertension and hypertensive end organ damage

Standard

The role of complement in arterial hypertension and hypertensive end organ damage. / Wenzel, Ulrich O; Kemper, Claudia; Bode, Marlies.

In: BRIT J PHARMACOL, Vol. 178, No. 14, 07.2021, p. 2849-2862.

Research output: SCORING: Contribution to journalSCORING: Review articleResearch

Harvard

APA

Vancouver

Bibtex

@article{53d22fbe5df74c0a98e3374cb05432e3,
title = "The role of complement in arterial hypertension and hypertensive end organ damage",
abstract = "Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage. LINKED ARTICLES: This article is part of a themed issue on Canonical and non-canonical functions of the complement system in health and disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.14/issuetoc.",
keywords = "Adaptive Immunity, Complement System Proteins, Humans, Hypertension, Immunity, Innate, Inflammation",
author = "Wenzel, {Ulrich O} and Claudia Kemper and Marlies Bode",
note = "{\textcopyright} 2020 The British Pharmacological Society.",
year = "2021",
month = jul,
doi = "10.1111/bph.15171",
language = "English",
volume = "178",
pages = "2849--2862",
journal = "BRIT J PHARMACOL",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "14",

}

RIS

TY - JOUR

T1 - The role of complement in arterial hypertension and hypertensive end organ damage

AU - Wenzel, Ulrich O

AU - Kemper, Claudia

AU - Bode, Marlies

N1 - © 2020 The British Pharmacological Society.

PY - 2021/7

Y1 - 2021/7

N2 - Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage. LINKED ARTICLES: This article is part of a themed issue on Canonical and non-canonical functions of the complement system in health and disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.14/issuetoc.

AB - Increasing evidence indicates that hypertension and hypertensive end organ damage are not only mediated by haemodynamic injury but that inflammation also plays an important role. The complement system protects the host from a hostile microbial environment and maintains tissue and cell integrity through the elimination of altered or dead cells. As an important effector arm of innate immunity, it plays also central roles in the regulation of adaptive immunity. Thus, complement activation may drive the pathology of hypertension through its effects on innate and adaptive immune responses, aside from direct effects on the vasculature. Recent experimental data strongly support a role for complement in all stages of arterial hypertension. The remarkably similar clinical and histopathological features of malignant nephrosclerosis and atypical haemolytic uraemic syndrome suggest also a role for complement in the development of malignant nephrosclerosis. Here, we review the role of complement in hypertension and hypertensive end organ damage. LINKED ARTICLES: This article is part of a themed issue on Canonical and non-canonical functions of the complement system in health and disease. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v178.14/issuetoc.

KW - Adaptive Immunity

KW - Complement System Proteins

KW - Humans

KW - Hypertension

KW - Immunity, Innate

KW - Inflammation

U2 - 10.1111/bph.15171

DO - 10.1111/bph.15171

M3 - SCORING: Review article

C2 - 32585035

VL - 178

SP - 2849

EP - 2862

JO - BRIT J PHARMACOL

JF - BRIT J PHARMACOL

SN - 0007-1188

IS - 14

ER -